SecBot SecBot
SECBOTREPLAY Home › Report › IMTX

IMTX · Immatics reported Q1 2026 EPS of -$0.29, a 33.9% beat vs consensus of…

https://immatics.com/ · PRESS-RELEASE filed May 12, 2026 at 07:00 ET

At the news

MIXEDIMPACT 6/10

PRESS-RELEASE filed May 12, 2026 at 07:00 ET

Immatics reported Q1 2026 EPS of -$0.29, a 33.9% beat vs consensus of -$0.44, but revenue fell sharply to $8.7M from $21.4M YoY due to lower collaboration cost recognition. The net loss widened to $66.5M from a prior-year net profit of $45.9M, driven by higher R&D spending on the SUPRAME Phase 3 trial and early commercial preparations. The stock's move will hinge on the upcoming SUPRAME interim/final analysis triggers in 2026 and multiple ASCO data readouts, not the mixed quarterly financials.

  • EPS of -$0.29 beat consensus of -$0.44 by 33.9%
  • Revenue of $8.7M declined 59.3% YoY from $21.4M due to lower collaboration cost recognition
  • Net loss of $66.5M vs net profit of $45.9M in Q1 2025
  • Cash and financial assets of $521.5M as of March 31, 2026, with cash reach projected into 2028

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access